Status:

UNKNOWN

A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis

Lead Sponsor:

Beijing Ditan Hospital

Conditions:

Chronic Hepatitis b

Eligibility:

All Genders

18-75 years

Brief Summary

This was a retrospective observational cohort study. The patients with chronic hepatitis B and cirrhosis who were treated with antiviral therapy in the Second Department of Liver Disease, Beijing Dita...

Detailed Description

This was a retrospective observational cohort study. The patients with chronic hepatitis B and cirrhosis who were treated with antiviral therapy in the Second Department of Liver Disease, Beijing Dita...

Eligibility Criteria

Inclusion

  • Ages 18 to 75;
  • Unlimited gender;
  • Patients with chronic hepatitis B treated with interferon and / or nucleoside (acid) analogs (NA) antiviral therapy. All patients with chronic hepatitis B met the diagnostic criteria of the Chinese Guidelines for the Prevention and Treatment of Chronic Hepatitis B (2015)
  • No hormones and / or immunosuppressants and other hepatoprotective drugs;
  • Sign a written informed consent.

Exclusion

  • Combined with other hepatitis virus (HCV, HDV) infections;
  • Immune liver disease;
  • HIV infection;
  • long-term alcohol and / or other liver damage drugs;
  • mental illness;
  • Evidence of liver tumor (liver cancer or AFP\> 100 ng / ml);
  • Decompensated cirrhosis;
  • Those who have serious heart, brain, lung, kidney and other system diseases that cannot participate in long-term follow-up;
  • There are hormones and / or immunosuppressants and other hepatoprotective drugs.

Key Trial Info

Start Date :

April 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2021

Estimated Enrollment :

10000 Patients enrolled

Trial Details

Trial ID

NCT04301908

Start Date

April 1 2020

End Date

April 1 2021

Last Update

March 10 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Hepatology Division 2, Beijing Ditan Hospital

Beijing, Beijing Municipality, China, 100015

A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis | DecenTrialz